Prethyroidectomy voice and swallowing disorders and the possible role of laryngopharyngeal reflux disease

2021 ◽  
pp. 1-6
Author(s):  
Linda Sõber ◽  
Urmas Lepner ◽  
Ülle Kirsimägi ◽  
Priit Kasenõmm
Keyword(s):  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Swallowing Disorders ◽  
Laryngopharyngeal Reflux Disease

scholarly journals The role of magnesium supplement in laryngopharyngeal reflux disease

2021 ◽  
Vol 8 (1) ◽  
pp. 47
Author(s):  
Adhira Gobind
Keyword(s):  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Tertiary Care ◽  
Treatment Protocol ◽  
Care Hospital ◽  
Reflux Symptom Index ◽  
Symptom Index ◽  
Regular Treatment ◽  
Laryngopharyngeal Reflux Disease

<p class="abstract"><strong>Background:</strong> Laryngopharyngeal reflux disease (LPRD) is one of the most prevalent upper gastrointestinal disorder encountered in clinical practice and its optimal treatment is not standardized. The role of magnesium in the human body functions is often underestimated. Since magnesium (Mg) plays a major role in the regulation of smooth muscle contractionby relaxing the pyloric sphincter and enhancing gastric emptying, thereby decreasing the pressure on the LES, it was hypothesized that adding magnesium supplements along with the regular treatment for LPRD, can improve LPRD symptoms. Magnesium has a neutralizing action on the gastric acid and therefore, it may be pertinent to achieve optimal Mg intakes in patients with LPRD.</p><p class="abstract"><strong>Methods:</strong> This is a prospective study done over a period of 1 year conducted in a tertiary care hospital in central India in patients presenting with LPRD of the age group 18-65 years.  </p><p class="abstract"><strong>Results:</strong> The study patients were divided into two groups-one treated with esmoprazole 40 mg capsules and alginate syrup and the other with esmoprazole capsules, alginate syrup and magnesium glycinate (250 mg) supplement. Both the groups showed appreciable improvement in their mean reflux symptom index (RSI) and reflux finding score (RFS) at 1 month and 3 months follow-up. Females showed a higher preponderance than males in the disease, symptoms and the mean RSI and RFS score.</p><p class="abstract"><strong>Conclusions:</strong> Addition of magnesium supplements along with the regular treatment for LPRD, can improve LPRD symptoms and should be considered in the treatment protocol of LPRD.</p>

scholarly journals The Role of Helicobacter Pylori in The Causation of Laryngopharyngeal Disorder in Specialized Allergic Center /Kirkuk-Iraq

2020 ◽  
Vol 3 (2) ◽  
pp. 201-207
Author(s):  
Diyar Majeed ◽  
karim jameel ◽  
suhaila Tahir
Keyword(s):  
Helicobacter Pylori ◽  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Serum Test ◽  
Laryngopharyngeal Reflux Disease ◽  
Common Manifestation

Laryngopharyngeal reflux disease is a common manifestation of GERD, about 10% of cases presented to ENT department. Out of 56 cases tested for H.pylori ,36 were positive for serum test and 20 cases were positive for both serum and stool.75% of cases responded to treatment of GERD with no recurrence

The Role of GastricHelicobacter PyloriInfection in Laryngopharyngeal Reflux Disease

2006 ◽  
Vol 135 (1) ◽  
pp. 52-55 ◽  
Author(s):  
İIbrahim Ercan ◽  
Burak Ömür Çakir ◽  
Tulin Çentürk Uzel ◽  
Damlanur Sakiz ◽  
Çetin Karaca ◽  
...  
Keyword(s):  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Laryngopharyngeal Reflux Disease

Optimal Regimen and Period for the Treatment of Patients with Laryngopharyngeal Reflux Disease

2014 ◽  
Vol 57 (10) ◽  
pp. 698 ◽  
Author(s):  
Yun Jae Lee ◽  
Min Kyu Kwak ◽  
Ji Hun Eom ◽  
Yong Bae Ji ◽  
Chang Myeon Song ◽  
...  
Keyword(s):  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Laryngopharyngeal Reflux Disease ◽  
Optimal Regimen

Influence of Helicobacter pylori Infection on Laryngopharyngeal Reflux Disease

2006 ◽  
Vol 57 (3) ◽  
pp. 268-272
Author(s):  
Ray Motohashi ◽  
Yusuke Watanabe ◽  
Ryoji Tokashiki ◽  
Kazuhiro Nakamura ◽  
Mamoru Suzuki
Keyword(s):  
Helicobacter Pylori ◽  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Helicobacter Pylori Infection ◽  
Laryngopharyngeal Reflux Disease

Modified Reflux Scintigraphy Detects Pulmonary Microaspiration in Severe Gastro-Esophageal and Laryngopharyngeal Reflux Disease

Lung ◽  
2021 ◽  
Vol 199 (2) ◽  
pp. 139-145
Author(s):  
Jin-soo Park ◽  
Leticia Burton ◽  
Hans Van der Wall ◽  
Gregory Leighton Falk
Keyword(s):  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Laryngopharyngeal Reflux Disease

A Randomized Clinical Trial of Proton Pump Inhibitors Combined with Traditional Chinese Medicine in the Treatment of Laryngopharyngeal Reflux Disease

2021 ◽  
Author(s):  
Feng Pei ◽  
Wei Jia Hu ◽  
Yi Nan Mao ◽  
Yu Liang Zhao
Keyword(s):  
Proton Pump ◽  
Reflux Disease ◽  
Laryngopharyngeal Reflux ◽  
Short Form ◽  
Therapeutic Effects ◽  
Reflux Symptom Index ◽  
Symptom Index ◽  
Laryngopharyngeal Reflux Disease ◽  
Group A ◽  
Group B

Background:To explore whether combined with TCM based on classical proton pumpinhibitors PPIs therapy can achieve better efficacy for patients withlaryngopharyngeal reflux disease. Methods: There were 150 laryngopharyngeal refluxpatients enrolled and divided into three groups randomly, with 50 cases in each group.Patients in group A were treated with the proton pump inhibitor (PPI) lansoprazole.Patients in group B were treated with lansoprazole combined with Banxia Houpudecoction, and patients in group C were treated with acupuncture treatments and acombination of Chinese and Western medicine. The reflux symptom index (RSI), refluxfinding score (RFS), and quality of life (36 item short form health survey questionnaire)were assessed before and 4 and 8 weeks after treatment. Results: The RSI and RFSscores of the three groups were significantly reduced after treatment (P < 0.001). Ingroup B and C, they were lower than in group A at 8 weeks (P < 0.01). The SF 36 scoreof 3 groups increased after treatment. At both 4 and 8 weeks (P < 0.001), and patientsin groups B and C scored higher than patients in group A (P < 0.001). The total effectiverate of group B and group C was higher than that of group A (P < 0.05). Conclusion:All three treatments have therapeutic effects on the disease, but the efficacy of a PPIalone is not as good as the combined treatments’ efficacies. Moreover, PPI combinedwith Banxia Houpu decoction and/or acupuncture treatment substantially affects lifeimprovement.

Sign in / Sign up

Export Citation Format

Share Document